Enteral nutrition has a positive effect on growth in children with active Crohn's disease. The question arises: is this is due only to improved nutrition? Enteral formulas may also directly reduce inflammation, lowering the expression of cytokines like interleukin (IL)-6 that inhibit growth. Four lines of evidence support the hypothesis that enteral formulas directly lessen inflammation: enteral nutrition directly affects the inflamed intestine; changes in inflammatory markers precede repletion of nutrition status; molecular pathways exist linking changes in luminal contents to the expression of class II MHC genes in intestinal epithelium in animal studies; and enteral formulas have a direct effect on cytokine expression by intestinal epithelial cells.
Get full access to this article
View all access options for this article.
References
1.
1. Brain CE, Savage MO. Growth and puberty in chronic inflammatory bowel disease. Baillieres Clin Gastroenterol.1994;8:83–100.
2.
2. Aiges H, Markowitz J, Rosa J, Daum F. Home nocturnal supplemental nasogastric feedings in growth-retarded adolescents with Crohn's disease. Gastroenterology.1989;97:905–910.
3.
3. Kirschner BS, Klich JR, Kalman SS, et al. Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Gastroenterology.1981;80:10–15.
4.
4. Kelts DG, Grand RJ, Shen G, et al. Nutritional basis of growth failure in children and adolescents with Crohn's disease. Gastro-enterology.1979;76:720–727.
5.
5. Murch SH, Lamkin VA, Savage MO, et al. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut.1991;32:913–917.
6.
6. MacDonald TT, Hutchings P, Choy MY, et al. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol.1990;81:301–305.
7.
7. De Benedetti F, Alonzi T, Moretta A, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest.1997;99:643–650.
8.
8. Ballinger AB, Azooz O, El Haj T, et al. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut.2000;46:694–700.
9.
9. Sanderson IR, Udeen S, Davies PSW, et al. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child.1987;62:123–127.
11. Banerjee K, Camacho-Hubner C, Babinska K, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr.2004;38:270–275.
12.
12. O'Morain C, Segal AW, Levi AJ. Elemental diets in treatment of acute Crohn's disease. Br Med J.1980;281:1173–1175.
13.
13. Morin CL, Roulet M, Roy CC, et al. Continuous elemental enteral alimentation in the treatment of children and adolescents with Crohn's disease. JPEN J Parenter Enteral Nutr.1982: 194–199.
14.
14. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J.1984;288:1859–1862.
15.
15. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr.1993;17:75–81.
16.
16. Sanderson IR, Boulton P, Menzies I, Walker-Smith JA. Improvement of abnormal lactulose/rhamnose permeability in active Crohn's disease of the small bowel by an elemental diet. Gut.1987;28:1073–1076.
17.
17. Beattie RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther.1994;8:609–615.
18.
18. Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther.2000;14:281–289.
19.
19. Heuschkel RB, MacDonald TT, Monteleone G, et al. Imbalance of stromelysin-1 and TIMP-1 in the mucosal lesions of children with inflammatory bowel disease. Gut.2000;47:57–62.
20.
20. Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology.1990;98:811–818.
21.
21. Sanderson IR. Short chain fatty acid regulation of signaling genes expressed by intestinal epithelium. J Nutr.2004;134: 2450S–2454S.
22.
22. Sanderson IR, Ouellette AJ, Carter EA, Harmatz PR. Ontogeny of Ia messenger RNA in the mouse intestinal epithelium is modulated by age of weaning and diet. Gastroenterology.1993;105:974–980.
23.
23. Sanderson IR, Bustin SA, Dzennis S, et al. Age and diet act through distinct isoforms of the class II transactivator gene in mouse intestinal epithelium. Gastroenterology.2004;127:203–212.
